Effects of different doses of streptozotocin on islet structure and main cell component in mice

魏蕊,谷良标,杨进,葛李娜,洪天配
DOI: https://doi.org/10.3969/j.issn.1006-6187.2017.12.012
2017-01-01
Abstract:Objective To investigate islet structure and cell component in diabetic mice induced by different doses of streptozotocin(STZ). Methods Sixteen male C57BL/6 mice were randomized into four groups,and were given 125,150 and 175 mg/kg STZ or citrate buffer by intraperitoneal injection respectively. Body weight,blood glucose,plasma insulin and glucagon levels were monitored before injection,and 3 d,7 d and 13 d after injection. Islet morphology and cell numbers were detected by immunofluorescence. Results Body weight was lower in all the STZ treatment groups than in control group(P= 0.002). Fasting blood glucose(FBG)levels in all the three groups of STZ-treatment were higher than in control group(P<0.001). Importantly,random blood glucose levels in all the three groups of STZ-treatment were ≥ 16.7 mmol/L. Plasma insulin levels in all the three groups of STZ-treatment were significantly lower than in control group in a dose-dependent manner(P= 0.027),whereas plasma glucagon levels did not show any changes between different groups. Immunofluorescence analyses showed that islet mass shrunk,accompanying with different degrees of residual islet βcells,in all the three groups of STZ-treatment. Notably,the number of αcells was remarkably more in 175 mg/kg STZ group than in the other two doses of STZ groups and even in control group(P<0.001). The number of islet.and PP cells did not show any differences between different groups. Conclusion The three different doses of STZ can induce diabetes in mice. Nevertheless,the structure of islet and the number of αandβcell display remarkable difference after treatment with the different doses of STZ.
What problem does this paper attempt to address?